112 related articles for article (PubMed ID: 23192205)
1. An elevated arterial enhancement fraction is associated with clinical and imaging indices of liver fibrosis and cirrhosis.
Bonekamp D; Bonekamp S; Geiger B; Kamel IR
J Comput Assist Tomogr; 2012; 36(6):681-9. PubMed ID: 23192205
[TBL] [Abstract][Full Text] [Related]
2. Assessing liver fibrosis: comparison of arterial enhancement fraction and diffusion-weighted imaging.
Bonekamp D; Bonekamp S; Ou HY; Torbenson MS; Corona-Villalobos CP; Mezey E; Kamel IR
J Magn Reson Imaging; 2014 Nov; 40(5):1137-46. PubMed ID: 24989329
[TBL] [Abstract][Full Text] [Related]
3. Quantitative color mapping of the arterial enhancement fraction in patients with diffuse liver disease.
Kang SE; Lee JM; Klotz E; Kim KW; Kim JH; Han JK; Choi BI
AJR Am J Roentgenol; 2011 Oct; 197(4):876-83. PubMed ID: 21940575
[TBL] [Abstract][Full Text] [Related]
4. The Liver Segmental Volume Ratio for Noninvasive Detection of Cirrhosis: Comparison With Established Linear and Volumetric Measures.
Furusato Hunt OM; Lubner MG; Ziemlewicz TJ; Muñoz Del Rio A; Pickhardt PJ
J Comput Assist Tomogr; 2016; 40(3):478-84. PubMed ID: 26966951
[TBL] [Abstract][Full Text] [Related]
5. The clinical value of hepatic extracellular volume fraction using routine multiphasic contrast-enhanced liver CT for staging liver fibrosis.
Guo SL; Su LN; Zhai YN; Chirume WM; Lei JQ; Zhang H; Yang L; Shen XP; Wen XX; Guo YM
Clin Radiol; 2017 Mar; 72(3):242-246. PubMed ID: 28341030
[TBL] [Abstract][Full Text] [Related]
6. Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT.
Ronot M; Asselah T; Paradis V; Michoux N; Dorvillius M; Baron G; Marcellin P; Van Beers BE; Vilgrain V
Radiology; 2010 Jul; 256(1):135-42. PubMed ID: 20574090
[TBL] [Abstract][Full Text] [Related]
7. MRI arterial enhancement fraction in hepatic fibrosis and cirrhosis.
Ou HY; Bonekamp S; Bonekamp D; Corona-Villalobos CP; Torbenson MS; Geiger B; Kamel IR
AJR Am J Roentgenol; 2013 Oct; 201(4):W596-602. PubMed ID: 24059398
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis.
Pickhardt PJ; Malecki K; Kloke J; Lubner MG
AJR Am J Roentgenol; 2016 Dec; 207(6):1194-1199. PubMed ID: 27575867
[TBL] [Abstract][Full Text] [Related]
9. Transient elastography is a useful noninvasive tool for the evaluation of fibrosis in paediatric chronic liver disease.
Fitzpatrick E; Quaglia A; Vimalesvaran S; Basso MS; Dhawan A
J Pediatr Gastroenterol Nutr; 2013 Jan; 56(1):72-6. PubMed ID: 22922372
[TBL] [Abstract][Full Text] [Related]
10. Quantitative CT color mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma.
Kim KW; Lee JM; Klotz E; Park HS; Lee DH; Kim JY; Kim SJ; Kim SH; Lee JY; Han JK; Choi BI
Radiology; 2009 Feb; 250(2):425-434. PubMed ID: 19188314
[TBL] [Abstract][Full Text] [Related]
11. Assessment of liver fibrosis severity using computed tomography-based liver and spleen volumetric indices in patients with chronic liver disease.
Son JH; Lee SS; Lee Y; Kang BK; Sung YS; Jo S; Yu E
Eur Radiol; 2020 Jun; 30(6):3486-3496. PubMed ID: 32055946
[TBL] [Abstract][Full Text] [Related]
12. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity.
Van Beers BE; Leconte I; Materne R; Smith AM; Jamart J; Horsmans Y
AJR Am J Roentgenol; 2001 Mar; 176(3):667-73. PubMed ID: 11222202
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Deep Learning System for Staging Liver Fibrosis by Using Contrast Agent-enhanced CT Images in the Liver.
Choi KJ; Jang JK; Lee SS; Sung YS; Shim WH; Kim HS; Yun J; Choi JY; Lee Y; Kang BK; Kim JH; Kim SY; Yu ES
Radiology; 2018 Dec; 289(3):688-697. PubMed ID: 30179104
[TBL] [Abstract][Full Text] [Related]
14. Estimation of hepatic extracellular volume fraction using multiphasic liver computed tomography for hepatic fibrosis grading.
Yoon JH; Lee JM; Klotz E; Jeon JH; Lee KB; Han JK; Choi BI
Invest Radiol; 2015 Apr; 50(4):290-6. PubMed ID: 25493416
[TBL] [Abstract][Full Text] [Related]
15. Cirrhotic liver enhancement on dual-phase helical CT: comparison with noncirrhotic livers in 146 patients.
Vignaux O; Legmann P; Coste J; Hoeffel C; Bonnin A
AJR Am J Roentgenol; 1999 Nov; 173(5):1193-7. PubMed ID: 10541087
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography.
Li N; Ding H; Fan P; Lin X; Xu C; Wang W; Xu Z; Wang J
Ultrasound Med Biol; 2010 Jul; 36(7):1066-75. PubMed ID: 20620694
[TBL] [Abstract][Full Text] [Related]
17. [CT-based estimation of liver function using arterial enhancement fraction in liver cirrhosis patients].
Rong P; Feng Z; Guo R; Zheng W; Hu Y; Li J; Wang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 May; 44(5):469-476. PubMed ID: 31303608
[TBL] [Abstract][Full Text] [Related]
18. Quantitative imaging: quantification of liver shape on CT using the statistical shape model to evaluate hepatic fibrosis.
Hori M; Okada T; Higashiura K; Sato Y; Chen YW; Kim T; Onishi H; Eguchi H; Nagano H; Umeshita K; Wakasa K; Tomiyama N
Acad Radiol; 2015 Mar; 22(3):303-9. PubMed ID: 25491738
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Vein Arrival Time for Diagnosis of Liver Cirrhosis: A 10-Year Single-Center Experience With Contrast-Enhanced Sonography.
Abbattista T; Ridolfi F; Consalvo GT; Brunelli E
J Ultrasound Med; 2016 Oct; 35(10):2121-8. PubMed ID: 27503751
[TBL] [Abstract][Full Text] [Related]
20. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy.
de Lédinghen V; Le Bail B; Rebouissoux L; Fournier C; Foucher J; Miette V; Castéra L; Sandrin L; Merrouche W; Lavrand F; Lamireau T
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):443-50. PubMed ID: 18030211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
